HRCM
VKTX icon

Hood River Capital Management’s Viking Therapeutics VKTX Stock Holding History

Hood River Capital Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-51,400
Closed -$1.24M – 174
2025
Q1 		$1.24M Buy
51,400
+7,870
+18% +$249K 0.02% 136
2024
Q4 		$1.75M Sell
43,530
-772,148
-95% -$44M 0.03% 140
2024
Q3 		$51.6M Buy
815,678
+101,100
+14% +$5.93M 0.83% 51
2024
Q2 		$37.9M Buy
714,578
+42,650
+6% +$2.8M 0.78% 49
2024
Q1 		$55.1M Buy
+671,928
New +$29.9M 1.23% 26

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM